BRPI0608077A2 - composição e composição de gel alcoólico dermatologicamente aceitáveis, método de fabricação e usos - Google Patents

composição e composição de gel alcoólico dermatologicamente aceitáveis, método de fabricação e usos

Info

Publication number
BRPI0608077A2
BRPI0608077A2 BRPI0608077-4A BRPI0608077A BRPI0608077A2 BR PI0608077 A2 BRPI0608077 A2 BR PI0608077A2 BR PI0608077 A BRPI0608077 A BR PI0608077A BR PI0608077 A2 BRPI0608077 A2 BR PI0608077A2
Authority
BR
Brazil
Prior art keywords
composition
compositions
alcoholic
dermatologically acceptable
manufacture
Prior art date
Application number
BRPI0608077-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Monique Spann-Wade
Anthony J Ward
Original Assignee
Isw Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/361,384 external-priority patent/US20070053984A1/en
Application filed by Isw Group Inc filed Critical Isw Group Inc
Publication of BRPI0608077A2 publication Critical patent/BRPI0608077A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0608077-4A 2005-03-03 2006-02-27 composição e composição de gel alcoólico dermatologicamente aceitáveis, método de fabricação e usos BRPI0608077A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US65808405P 2005-03-03 2005-03-03
US68110205P 2005-05-13 2005-05-13
US69020105P 2005-06-14 2005-06-14
US11/361,384 US20070053984A1 (en) 2005-03-03 2006-02-24 Topical gels compositions
PCT/US2006/006780 WO2006096360A1 (en) 2005-03-03 2006-02-27 Topical gels compositions

Publications (1)

Publication Number Publication Date
BRPI0608077A2 true BRPI0608077A2 (pt) 2009-11-10

Family

ID=42334238

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0608077-4A BRPI0608077A2 (pt) 2005-03-03 2006-02-27 composição e composição de gel alcoólico dermatologicamente aceitáveis, método de fabricação e usos

Country Status (10)

Country Link
EP (1) EP1858503B1 (enExample)
JP (1) JP2008531693A (enExample)
KR (1) KR20080008321A (enExample)
AU (1) AU2006220964A1 (enExample)
BR (1) BRPI0608077A2 (enExample)
CA (1) CA2599968A1 (enExample)
ES (1) ES2437201T3 (enExample)
IL (1) IL185531A0 (enExample)
MX (1) MX2007010681A (enExample)
WO (1) WO2006096360A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7914814B2 (en) 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
JP2007532697A (ja) 2004-04-19 2007-11-15 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー 局所的血流増大の有益な効果
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US20080317684A1 (en) * 2006-09-06 2008-12-25 Isw Group, Inc. Topical Compositions
ZA200903135B (en) 2006-10-17 2010-08-25 Nuvo Res Inc Diclofenac gel
ES2316312B1 (es) * 2008-06-20 2010-02-08 Ignacio Umbert Millet Composicion farmaceutica dermatologica para el tratamiento de patologias de inflamacion de la piel, tales como por ejemplo dermatitis, dermatitis atopica, vitiligo, alopecia areata, acne, psoriasis y prurito,y combinaciones de las mismas.
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
WO2010151241A1 (en) * 2009-06-24 2010-12-29 Strategic Science & Technologies, Llc Topical composition containing naproxen
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
AU2015203547B2 (en) * 2009-06-24 2017-05-18 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
CN102481275B (zh) 2009-06-24 2014-07-23 战略科学技术有限公司 含有布洛芬的表面组合物
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
JP2011106846A (ja) * 2009-11-13 2011-06-02 Hamamatsu Univ School Of Medicine 新規ｎｓａｉｄ潰瘍リスク判定方法
KR101141938B1 (ko) * 2010-01-22 2012-05-04 성균관대학교산학협력단 신규한 항생제 조성물 및 그람양성균의 치료 방법
WO2012092523A1 (en) 2010-12-29 2012-07-05 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
HRP20201512T1 (hr) 2010-12-29 2020-12-11 Strategic Science & Technologies, Llc Liječenje erektilne disfunkcije i drugih indikacija
HRP20191806T1 (hr) 2011-05-03 2020-01-10 Aponia Laboratories, Inc. Transdermalni pripravci ibuprofena i postupci za njihovu uporabu
CN106573155A (zh) 2014-02-26 2017-04-19 鲁玛治疗公司 紫外光疗设备和方法
WO2017139514A1 (en) 2016-02-09 2017-08-17 Luma Therapeutics, Inc. Methods, compositions and apparatuses for treating psoriasis by phototherapy
US20200230082A1 (en) * 2017-07-11 2020-07-23 University Of Miami Topical acetaminophen formulations for itch relief
US20230398060A1 (en) * 2020-05-19 2023-12-14 Mig Usa, Llc Topical compositions and methods for treating pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS596287B2 (ja) * 1980-11-28 1984-02-10 日東電工株式会社 医薬製剤
WO1987002891A1 (en) 1985-11-07 1987-05-21 Pfizer Inc. Compounds and method for the topical treatment of inflammation and pain
US5093133A (en) 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
US5639738A (en) 1992-02-20 1997-06-17 Hyal Pharmaceutical Corporation Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
US5976566A (en) 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin

Also Published As

Publication number Publication date
EP1858503B1 (en) 2013-09-04
MX2007010681A (es) 2007-12-07
EP1858503A1 (en) 2007-11-28
CA2599968A1 (en) 2006-09-14
IL185531A0 (en) 2008-01-06
KR20080008321A (ko) 2008-01-23
WO2006096360A1 (en) 2006-09-14
JP2008531693A (ja) 2008-08-14
AU2006220964A1 (en) 2006-09-14
ES2437201T3 (es) 2014-01-09

Similar Documents

Publication Publication Date Title
BRPI0608077A2 (pt) composição e composição de gel alcoólico dermatologicamente aceitáveis, método de fabricação e usos
MX2009006088A (es) Nanoemulsion.
WO2008008397A8 (en) Fatty acid pharmaceutical foam
BRPI0408476A (pt) métodos para melhorar a qualidade da pele
WO2009022338A3 (en) Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications
MX2009001203A (es) Muteinas de lipocalina lacrimosa y metodos para obtener las mismas.
EP2349279A4 (en) MODIFIERS OF ALDEHYDE DEHYDROGENASE AND METHODS OF USE THEREOF
BR112015005339A8 (pt) uso de óleo de semente de fruta milagrosa como um ingrediente ativo
WO2008070368A3 (en) Methods and compositions for skin care
EA201170876A1 (ru) Применение способной к вспениванию композиции, по существу, не содержащей фармацевтически активные ингредиенты, для лечения кожи человека
BR112015019657A8 (pt) composições tópicas, kit e método para aumentar a liberação de óxido nítrico a partir de um gel tópico anidro contendo uma macromolécula modificada de diazeniodiolato
WO2008139122A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
WO2007002831A3 (en) Topical skin treating compostions
BRPI0915439B8 (pt) composição de gel tópica, bem como uso de um agente ativo para tratamento de ceratose actínica em combinação com um agente ceratoliticamente ativo para preparação da referida composição
BR112014019623A8 (pt) Composição aditiva de condicionamento para o fornecimento benefícios de longa duração e imediatos para substratos de queratina
MX2010004613A (es) Composicion topica.
DK1982696T3 (da) Gel til behandling af sår
BRPI0508933A (pt) composições para entrega tópica
WO2011059324A3 (en) Composition for topical application, uses thereof, applicator device and kit of parts
WO2005000241A8 (en) Compositons and methods for topical administration
WO2007059979A3 (en) Allergy treatment by epicutaneous allergen administration
MX2011012143A (es) Composiciones adecuadas para el tratamiento topico o infecciones fungicas de la piel y uñas.
WO2009087354A3 (en) Skincare treatment
WO2008149035A3 (fr) Nouveau principe actif dans la cicatrisation et son utilisation
WO2015031971A8 (en) A composition comprising guaçatonga extract and aroeira extract/ use thereof and a method for preventing and/or treating signals caused by skin aging

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUI DADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2211 DE 21/05/2013.